immunology

LIVE December 8th, 2021 at 11:00 AM ET
Discover genes and variants that determine patient responses to immunotherapy

LIVE November 29th, 2021 at 11:00 AM ET
Investigating the pathophysiology and spread of human viruses

The commonly used ointment Neosporin may disrupt skin’s regenerative microbiome, delaying healing.

Researchers are conducting the first long-term prospective study to understand the immune response to COVID-19 long after initial infection.

Promising results from clinical trials show that allergen tolerization works for many patients.

A naturally occurring nanoparticle yields a new type of vaccine that offers broad-acting protection against emerging SARS-CoV-2 variants. With further development, the approach may lead to a pan-coronavirus vaccine.

Infectious diseases alter the traditional vaccine pipeline and spawn new approaches to antibody research and vaccine development.

Erica Ollman Saphire brings together scientific competitors to find new antibody therapeutics for COVID-19.

First patient has been dosed in Phase 3 avatrombopag study for the treatment of ITP in children

Fungi in the gut help in the fight against dangerous blood-borne fungal infections